These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11807830)

  • 1. Effect of age and hypoxia on TGFbeta1 receptor expression and signal transduction in human dermal fibroblasts: impact on cell migration.
    Mogford JE; Tawil N; Chen A; Gies D; Xia Y; Mustoe TA
    J Cell Physiol; 2002 Feb; 190(2):259-65. PubMed ID: 11807830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in scleroderma.
    Pannu J; Gore-Hyer E; Yamanaka M; Smith EA; Rubinchik S; Dong JY; Jablonska S; Blaszczyk M; Trojanowska M
    Arthritis Rheum; 2004 May; 50(5):1566-77. PubMed ID: 15146427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased levels of transforming growth factor beta receptor type I and up-regulation of matrix gene program: A model of scleroderma.
    Pannu J; Gardner H; Shearstone JR; Smith E; Trojanowska M
    Arthritis Rheum; 2006 Sep; 54(9):3011-21. PubMed ID: 16947635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
    Mori Y; Ishida W; Bhattacharyya S; Li Y; Platanias LC; Varga J
    Arthritis Rheum; 2004 Dec; 50(12):4008-21. PubMed ID: 15593186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of activin receptor-like kinase 5 (transforming growth factor beta receptor type I) signaling to the fibrotic phenotype of scleroderma fibroblasts.
    Chen Y; Shi-wen X; Eastwood M; Black CM; Denton CP; Leask A; Abraham DJ
    Arthritis Rheum; 2006 Apr; 54(4):1309-16. PubMed ID: 16575856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblasts from chronic wounds show altered TGF-beta-signaling and decreased TGF-beta Type II receptor expression.
    Kim BC; Kim HT; Park SH; Cha JS; Yufit T; Kim SJ; Falanga V
    J Cell Physiol; 2003 Jun; 195(3):331-6. PubMed ID: 12704642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular mechanisms and modulation of activin A- and transforming growth factor beta-mediated differentiation in cultured hen granulosa cells.
    Johnson AL; Bridgham JT; Woods DC
    Biol Reprod; 2004 Dec; 71(6):1844-51. PubMed ID: 15269104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal and adult human skin fibroblasts display intrinsic differences in contractile capacity.
    Moulin V; Tam BY; Castilloux G; Auger FA; O'Connor-McCourt MD; Philip A; Germain L
    J Cell Physiol; 2001 Aug; 188(2):211-22. PubMed ID: 11424088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic activation of extracellular signal-regulated kinase in human dermal fibroblasts by human telomerase reverse transcriptase and transforming growth factor-beta1.
    Liu WR; Lu L; Rosenberg DS; Procaccini PS; Mustoe TA
    J Surg Res; 2007 Dec; 143(2):415-21. PubMed ID: 17662305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of interferon-gamma on human subconjunctival fibroblasts in the presence of TGFbeta1: reversal of TGFbeta-stimulated collagen production.
    Yamanaka O; Saika S; Okada Y; Ooshima A; Ohnishi Y
    Graefes Arch Clin Exp Ophthalmol; 2003 Feb; 241(2):116-24. PubMed ID: 12605266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiostatic effects of aspirin in hypoxia-reoxygenation are linked to modulation of TGFβ1 signaling.
    Khaidakov M; Szwedo J; Mitra S; Mehta JL
    J Cardiovasc Pharmacol Ther; 2011 Mar; 16(1):105-10. PubMed ID: 20940449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-1beta impairment of transforming growth factor beta1 signaling by down-regulation of transforming growth factor beta receptor type II and up-regulation of Smad7 in human articular chondrocytes.
    Baugé C; Legendre F; Leclercq S; Elissalde JM; Pujol JP; Galéra P; Boumédiene K
    Arthritis Rheum; 2007 Sep; 56(9):3020-32. PubMed ID: 17763417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toremifene decreases type I, type II and increases type III receptors in desmoid and fibroma and inhibits TGFbeta1 binding in desmoid fibroblasts.
    Stabellini G; Balducci C; Lilli C; Marinucci L; Becchetti E; Carinci F; Calastrini C; Dolci C; Lumare E; Locci P
    Biomed Pharmacother; 2008 Sep; 62(7):436-42. PubMed ID: 18155395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of transforming growth factor-beta/Smad signaling between normal dermal fibroblasts and fibroblasts derived from central and peripheral areas of keloid lesions.
    Tsujita-Kyutoku M; Uehara N; Matsuoka Y; Kyutoku S; Ogawa Y; Tsubura A
    In Vivo; 2005; 19(6):959-63. PubMed ID: 16277007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of endogenous transforming growth factor beta signaling prevents up-regulated collagen synthesis in scleroderma fibroblasts: association with increased expression of transforming growth factor beta receptors.
    Ihn H; Yamane K; Kubo M; Tamaki K
    Arthritis Rheum; 2001 Feb; 44(2):474-80. PubMed ID: 11229480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression levels and the differential expression of transforming growth factor-beta receptors in dermatofibroma and dermatofibrosarcoma protuberans.
    Kubo M; Ihn H; Yamane K; Tamaki K
    Br J Dermatol; 2006 May; 154(5):919-25. PubMed ID: 16634896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II.
    Kalo E; Buganim Y; Shapira KE; Besserglick H; Goldfinger N; Weisz L; Stambolsky P; Henis YI; Rotter V
    Mol Cell Biol; 2007 Dec; 27(23):8228-42. PubMed ID: 17875924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-beta induces expression of vascular endothelial growth factor in human retinal pigment epithelial cells: involvement of mitogen-activated protein kinases.
    Nagineni CN; Samuel W; Nagineni S; Pardhasaradhi K; Wiggert B; Detrick B; Hooks JJ
    J Cell Physiol; 2003 Dec; 197(3):453-62. PubMed ID: 14566975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetaldehyde stimulates the activation of latent transforming growth factor-beta1 and induces expression of the type II receptor of the cytokine in rat cultured hepatic stellate cells.
    Chen A
    Biochem J; 2002 Dec; 368(Pt 3):683-93. PubMed ID: 12223100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.